1.   A human antibody to PTHrP, similar to the mouse antibody used in the study, may be beneficial.

2.   Abgenix is now conducting early clinical trials to prove that its XenoMouse human antibodies work better than the previous generation of modified mouse antibodies.

3.   ImmunoGen Inc. said it won a patent allowance on its technology for making mouse antibodies that appear human to the immune system.

4.   That prevents the human immune system from developing its own antibodies to fight the mouse antibodies, making the cancer treatment ineffective.

5.   The Cambridge, Massachusetts-based company said that as part of the technique, it resurfaces the mouse antibody with a human antibody.

6.   The mouse antibodies are being developed to treat intestine, lung and lymphoma cancers.

7.   The mouse antibodies, which are produced by the immune system to attack disease, carry potent drugs to the site of the cancer.

8.   The new treatment combines mouse antibodies with human antibodies to fool the immune system.

9.   The technique prevents humans from rejecting the mouse antibodies in long-term cancer treatments.

10.   Using the mouse antibody, developed by a Japanese biotech firm, they were able to prevent bone tumors from forming.